Showing results (281-290 of 453) with videos related to
Sort By:
Pageof 46
The Journal of Urology|March 5, 2013
Trends in partial and radical nephrectomy: an analysis of case logs from certifying urologistsStephen A Poon, Jonathan L Silberstein, Ling Y Chen, et al.The Journal of Urology|October 15, 2017
Biopsy Core Features are Poor Predictors of Adverse Pathology in Men with Grade Group 1 Prostate CancerFrançois Audenet, Emily A Vertosick, Samson W Fine, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen eraAndrew J Stephenson, Michael W Kattan, James A Eastham, et al.BJU International|March 2, 2013
Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?Sigrid V Carlsson, Mari T Peltola, Daniel Sjoberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2009
Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomyMatthew Frank O'Brien, Angel M Cronin, Paul A Fearn, et al.European Urology|February 25, 2015
Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the LiteratureLuis A Kluth, Peter C Black, Bernard H Bochner, et al.Head & Neck|July 20, 2024
Association between objective measures of oral health and salivary gland irradiation with patient-reported outcomes following head and neck radiation therapyAnnu Singh, Sallie M Long, Amy L Tin, et al.Annals of Surgical Oncology|February 25, 2021
Intraoperative Ketorolac is Associated with Risk of Reoperation After Mastectomy: A Single-Center ExaminationPatrick J McCormick, Melissa Assel, Kimberly J Van Zee, et al.Urology|August 20, 2022
Blood Prostate-specific Antigen by Volume of Benign, Gleason Pattern 3 and 4 Prostate TissueCiro Andolfi, Andrew J Vickers, Matthew R Cooperberg, et al.European Urology|August 30, 2014
The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened menMoniek M Vedder, Esther W de Bekker-Grob, Hans G Lilja, et al.Pageof 46